“Treatment of Relapsed Refractory CLL With Venetoclax-Rituximab During the COVID-19 Pandemic: A Daily-Life Experience in Southern Italy”. Mediterranean Journal of Hematology and Infectious Diseases, vol. 13, no. 1, June 2021, p. e2021042, https://doi.org/10.4084/MJHID.2021.042.